Tower Research Capital LLC (TRC) - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 53 filers reported holding ETON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,887
-68.0%
1,172
-73.2%
0.00%
-100.0%
Q2 2023$15,265
+117323.1%
4,374
+28.6%
0.00%
Q1 2023$13
+30.0%
3,401
-6.7%
0.00%
Q4 2022$10
-99.9%
3,647
-36.0%
0.00%
Q3 2022$12,000
+140.0%
5,700
+175.9%
0.00%
Q2 2022$5,000
-16.7%
2,066
+54.4%
0.00%
Q1 2022$6,000
-72.7%
1,338
-69.5%
0.00%
-100.0%
Q3 2021$22,000
+10.0%
4,382
+58.5%
0.00%
Q1 2021$20,000
+5.3%
2,764
+19.8%
0.00%
-100.0%
Q4 2020$19,000
-82.7%
2,308
-83.4%
0.00%0.0%
Q3 2020$110,000
+26.4%
13,936
-12.3%
0.00%
-75.0%
Q2 2020$87,00015,886
+72109.1%
0.00%
Q4 2019$0
-100.0%
22
-98.3%
0.00%
-100.0%
Q3 2019$8,000
-68.0%
1,307
-58.4%
0.00%
-50.0%
Q2 2019$25,000
+127.3%
3,139
+122.5%
0.00%
+100.0%
Q1 2019$11,000
+1000.0%
1,411
+787.4%
0.00%
Q4 2018$1,0001590.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,430,270$10,134,2263.30%
Westside Investment Management, Inc. 528,310$2,203,0600.63%
Acuitas Investments, LLC 219,000$913,2300.54%
EAM Investors, LLC 256,623$1,070,1180.21%
Parkman Healthcare Partners LLC 165,000$688,0500.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 110,016$458,7670.08%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,251,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 271,462$1,131,9970.03%
Quantum Private Wealth, LLC 11,500$47,9550.02%
CHICAGO TRUST Co NA 16,700$69,6390.02%
View complete list of ETON PHARMACEUTICALS INC shareholders